IndieBio accelerates biotech startups with up to $525K in funding, 8% equity, and expert support in research, product development, and market strategy.
IndieBio is one of the world’s leading accelerators for life sciences and biotechnology startups. Part of the SOSV family, IndieBio focuses on nurturing early-stage companies that are solving significant problems in human and planetary health. With locations in San Francisco and New York, IndieBio provides a unique environment where startups can access world-class laboratories, expert mentorship, and a network of investors who are passionate about biotech innovations.
The IndieBio program is intensive, typically lasting around four months, and is designed to accelerate the development of biotech startups from concept to viable product. Startups in the program receive hands-on support in areas such as scientific research, product development, regulatory strategy, and go-to-market planning. The program also offers a structured curriculum that helps founders navigate the complexities of building a biotech company, from securing intellectual property to scaling production.
IndieBio offers an investment of up to $525,000, which includes $250,000 in initial funding in exchange for an 8% equity stake. This funding is critical for startups to conduct research, develop prototypes, and prepare for commercial launch. Additionally, startups benefit from the extensive IndieBio alumni network, which provides ongoing support and opportunities for collaboration long after the program ends.
For startups focused on biotechnology and life sciences, IndieBio offers an unparalleled platform to accelerate their growth and bring their innovations to market.
Our pitch deck template will guide you through the requirements of an Accelerator-ready presentation.
